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Abstract
Background: Disseminated cutaneous herpes zoster in healthy persons is uncommon, though it
has been described in immunocompromised patients.
Case presentation: We describe a case of disseminated cutaneous herpes zoster in an elderly
man with no apparent immunosuppressive condition. The patient was treated successfully with
intravenous Acyclovir.
Conclusion: We suggest that disseminated zoster can occur in an immunocompetent host and
should be promptly recognized and treated to prevent serious complications.
Background
Disseminated cutaneous herpes zoster has been described
in persons with immunosuppression due to Human
Immunodeficiency Virus (HIV), hematological malig-
nancy, or chemotherapy. However, it is uncommon to see
dissemination of zoster in healthy individuals. In this
report, we describe the clinical course of a patient who
presented with disseminated cutaneous zoster in the
absence of a known immunosuppressive condition. A
brief review of literature on this topic is also presented.
Case Presentation
A previously healthy 69-year old man presented with a 5-
day history of severe pain over the right forehead and a 3-
day history of vesicular eruption over right forehead, right
eyelid, and nose. It was followed by the spread of vesicular
eruption to involve chest, back and bilateral upper and
lower extremities over next 2-days. Review of systems was
negative. The patient did not have a history of chickenpox
during childhood or any recent exposure to it. There was
no past history of diabetes, cardiac or pulmonary disease,
or lymphoma. The patient has not been on immunosup-
pressive or other medications.
On examination, the patient was afebrile (37.4°C). He
had vesicles and pustules, with crusting and swelling, in
the distribution of the ophthalmic division of the trigem-
inal nerve (V1) including its nasociliary branch. Both eye-
lids were swollen, tender and red. There was no corneal
involvement. Vesicles, pustules and scabs in various stages
were also present over trunk and extremities (Figure 1).
Palms and soles were spared and there was no lymphade-
nopathy. Pulmonary, cardiovascular and abdominal
examinations were normal.
Complete blood count, peripheral smear, routine bio-
chemistry, liver function tests, and chest x-ray were nor-
mal. CD4 and CD8 lymphocyte counts were 1.34 × 109/L
and 0.61 × 109/L respectively (CD4:CD8 ratio = 2.2).
Serology for Human Immunodeficiency Virus (HIV),
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Picture of the patient showing diffuse vesicular, pustular and crusted lesions with concentration of the eruption in ophthalmic d vision (V1) of trigeminal nerveFig 1
Picture of the patient showing diffuse vesicular, pustular and crusted lesions with concentration of the eruption in ophthalmic 
division (V1) of trigeminal nerve.
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and RPR was non-reactive. The blood and vesicle culture
for Varicella Zoster Virus (VZV) were negative. Serum VZV
Immunoglobulin G (IgG) and Immunoglobulin M (IgM)
done six days after the onset of dissemination were posi-
tive (the titers were not obtained). Skin biopsy from fresh
vesicle on the trunk and forearm showed ulceration with
acute inflammation, necrosis and intranuclear inclusions
within epithelial cells. The direct fluorescence antigen
staining from skin lesions was positive for VZV.
The patient was started on intravenous Acyclovir 800 mg
every 8 hours. In the next 24 hours, the eruption of new
vesicles ceased, the rash started to resolve and his clinical
status improved. I.V. Acyclovir was continued for four
more days and the patient discharged on oral acyclovir
800 mg 5 times daily for 16 days.
Discussion
Herpes zoster, also called shingles is the consequence of
reactivation of latent VZV from the dorsal root ganglia. It
is characterized by unilateral vesicular eruptions within a
dermatome. Disseminated cutaneous zoster has been
defined as more than 20 vesicles outside the area of the
primary and adjacent dermatomes [1]. This complication
of zoster has been described in immunocompromised
persons (HIV, cancer, patients on immunosuppressive
therapy) and reported to be as common as 10% – 40%
[1,2]. However, disseminated cutaneous zoster in other-
wise healthy persons who are not on immunosuppressive
therapy and have no underlying cancer is rare. In our
search on PubMed using the keywords "zoster", "dissemi-
nated zoster", "immunocompetent", we could identify
less than ten cases with disseminated zoster in otherwise
healthy persons [3-5].
Our patient presented with characteristic skin findings of
disseminated cutaneous herpes zoster. Dissemination
occurred by third day of the eruption. The serology and
skin biopsy findings supported the clinical diagnosis of
VZV. VZV IgM is extremely rare during VZV reactivation,
and even if positive, the titers are not very high. The vesicle
culture for VZV was negative, however VZV is a fastidious
virus and the sensitivity of culture is approximately 20%
[6].
In our patient, significant age related depression in cellu-
lar immunity could have contributed to the dissemination
of herpes zoster. Elderly patients should be recognized as
a group in whom the risk of dissemination is higher than
the average immunocompetent host. Patients with cuta-
neous dissemination of VZV are at risk of infection of vis-
ceral organs, particularly lungs, liver and brain. Other
complications include corneal ulceration and post her-
petic neuralgia[1]. Therefore, identification and aggressive
treatment of disseminated herpes zoster infection in eld-
erly immunocompetent hosts is important. The treatment
of choice for disseminated zoster is intravenous Acyclovir
10 mg/kg every 8 hours for 5–7 days.
Conclusion
Disseminated herpes zoster is a potentially serious infec-
tion that can present in the absence of immunosuppres-
sion. Early diagnosis and aggressive treatment with
intravenous acyclovir can reduce morbidity and severity
of complications.
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